CoChat

Contributions of GABAAReceptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders

Ator, Nancy A. · 2005 · CNS Spectrums

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abstract

When benzodiazepines (BZs) supplanted barbiturates as a favored, safer treatment for anxiety and sleep disorders in the 1960s, the abuse liability and dependence potential of these drugs were little understood. Widespread recognition of the difficulty of stopping use of chronically taken BZs emerged through the popular press in the late 1970s, which resulted in reluctance to prescribe these otherwise clinically useful compounds. Evolution of the understanding of the biochemical basis for BZ effects in the 1980s and 1990s, coupled with regulatory emphasis on collection of data used in legal scheduling decisions, made possible a targeted search for drugs that would provide effective treatment for anxiety disorders in the absence of abuse liability or dependence potential. Compounds that have selective efficacy at subtypes of the γ-aminobutyric acid type A receptor, are active in preclinical anxiolytic screens, but negative in preclinical studies of behavior relevant to evaluation of abuse liability appear to be one promising means for achieving this end.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852900009883

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Research works printed but not linked: 6

  1. Lader, 1987, Benzodiazepine dependence. ISI Atlas of Science: Pharmacology, 299
  2. 10.1037/1064-1297.8.3.294 · doi:10.1037/1064-1297.8.3.294
  3. 2001, Thirty-Second Report
  4. Rush, 2001, Animal Research and Human Health, 101
  5. Yanagita, 1983, Problems of Drug Dependence, 1982; Proceedings of the 44th Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Inc. NIDA Research Monograph Series 43, 164
  6. Ator, Drug Alcohol Depend

Cited by

See all 59

Metadata

Authors
Ator, N. A.
Affiliations
Johns Hopkins University (US)
Corresponding author
Ator, Nancy A.
Venue
CNS Spectrums
Published
2005-01
Volume
10
Issue
1
Pages
31-39
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2404476850
Cited by
59
References
61
Citations by year
2026: 2 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 4
FWCI
0.40
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01-DA-04133, R01DA004133)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
GABAA receptor subtypes, benzodiazepines, abuse liability, anxiolytics, sleep disorders, anxiety disorders, drug scheduling, barbiturates
MeSH terms
Anxiety Disorders, Benzodiazepines, Binding, Competitive, Humans, Receptors, GABA-A, Self Administration, Sleep Wake Disorders, Liability, Legal, GABA Modulators, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contributions of GABAAReceptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders. https://app.cochat.ai/papers/10.1017/s1092852900009883
The paper
Ator, N. A. (2005). Contributions of GABAAReceptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900009883

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.